Assessment of Urinary Kidney Injury Molecule-1 in the Early Post-Burn Period to Predict Acute Kidney Injury for Various Degrees of Burn
Asian Journal of Research in Nephrology,
Background: Acute kidney injury (AKI) is defined as a sudden and rapid decline in renal excretory function within hours to days, accompanied by an accumulation of nitrogenous waste products such as creatinine, urea, and other clinically unmeasured products. Historically acute kidney injury has carried a bad prognosis in the burn population.
Objective: To evaluate urinary kidney injury molecule-1 in the early post-burn period to predict acute kidney injury for various degrees of burn.
Methods: This prospective observational study was conducted in the Department of Nephrology, Dhaka Medical College Hospital, over one year from July 2016 to June 2017. 43 burn patients were enrolled in this study. Serum creatinine, BUN, and KIM-1 were measured on admission and within 48 hours of admission. SPSS 22.0 was used to analyze data. Kappa statistics were done, and AUC was calculated for KIM-1 to predict AKI.
Results In this study, most of the burn patients were below 35 years old. The mean age of the burn patients was 31.39±10.69 years. Males were predominant in burn patients. Maximum burns were due to flame (67.9%), and seven were from scald (13.2%). Mean TBSA was 30.62±14.89%. TBSA, serum creatinine, KIM-1 were significantly high in severe burn patients comparing mild and moderate burn patients. In this study, AKI was developed among 12 (27.9%) burn patients. TBSA was significantly high in AKI patients. Within 2 hours of admission, serum creatinine and BUN were normal in AKI and non-AKI patients, but the KIM-1 level was increased in AKI patients. By 48 hours of admission, urinary KIM-1, serum creatinine, and blood urea nitrogen were significantly higher in AKI patients comparing non-AKI patients.
Conclusion: Urinary KIM-1 is a valuable biomarker in predicting early AKI in burn patients. Our study suggests that urinary KIM-1 may be used as early, sensitive indicators of AKI in patients with burns of varying degrees and provide clinical clues for early AKI prevention.
- burn patients
How to Cite
Ricci Z, Cruz DN, Ronco C. Classification and staging of acute kidney injury: Beyond the RIFLE and AKIN criteria. Nature Reviews Nephrology. 2011;7(4):201-208.
Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Critical care medicine. 2006;34(7):1913-1917.
Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73:1008-16.
Mårtensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability. British journal of anesthesia. 2012;109(6):843-850.
Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Critical care. 2007;11(2):R31.
Mischak H, Delles C, Vlahou A, Vanholder R. Proteomic biomarkers in kidney disease: Issues in development and implementation. Nature Reviews Nephrology. 2015;11(4):221-232.
Ren H, Zhou X, Dai D, Liu X, Wang L, Zhou Y. Assessment of urinary kidney injury molecule-1 and interleukin-18 in the early post-burn period to predict acute kidney injury for various degrees of burn injury. BMC nephrology. 2015;16(1):142.
Liu Y, Guo W, Zhang J, Xu C, Yu S, Mao Z. Urinary interleukin 18 for detection of acute kidney injury: A meta-analysis. American Journal of Kidney Diseases. 2013;62(6):1058-1067.
Palmieri T, Lavrentieva A, Greenhalgh D. An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns. Intensive care medicine. 2009;35(12):2125.
Coca SG, Bauling P, Schifftner T, Howard CS, Teitelbaum I, Parikh CR. Contribution of acute kidney injury toward morbidity and mortality in burns: A contemporary analysis. American Journal of Kidney Diseases. 2007;49(4):517-523.
Kallinen O, Maisniemi K, Böhling T, Tukiainen E, Koljonen V. Multiple organ failure as a cause of death in patients with severe burns. Journal of Burn Care & Research. 2012;33(2):206-211.
Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D. Evaluation and initial management of acute kidney injury. Clinical Journal of the American Society of Nephrology. 2008;3(4):962-967.
Yavuz S, Anarat A, Acartürk S, Dalay AC, Kesiktaş E, Yavuz M. Neutrophil gelatinase associated lipocalin as an indicator of acute kidney injury and inflammation in burned children. Burns. 2014;40(4):648-654.
Adiyanti SS, Loho T. Acute kidney injury (AKI) biomarker. Acta Med Indones. 2012;44(3):246-55.
Vaidya VS, Waikar SS, Ferguson MA, Collings FB, Sunderland K, Gioules C. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clinical and translational science. 2008;1(3):200-208.
Xiao J, Niu J, Ye X, Yu Q, Gu Y. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Hypertension in pregnancy. 2013;32(4):439-449.
Yang HT, Yim H, Cho YS, Kym D, Hur J, Kim JH. Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: Comparison of serum creatinine, serum Cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin. Critical care. 2014;18(4):R151.
Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Journal of Biological Chemistry. 1998;273(7):4135-4142.
Lim AI, Tang SC, Lai KN, Leung JC. Kidney injury molecule‐1: More than just an injury marker of tubular epithelial cells. Journal of cellular physiology. 2013;228(5):917-924.
Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney international. 2002;62(1):237-244.
Waikar SS, Bonventre JV. Biomarkers for the diagnosis of acute kidney injury. Nephron Clinical Practice. 2008;109(4):c192-c197.
Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicological Sciences. 2008;101(1):159-170.
Duan SB, Liu GL, Yu ZQ, Pan P. Urinary KIM-1, IL-18 and Cys-C as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients. Clinical nephrology. 2013;80(5):349-354.
Legrand M, Payen D. Understanding urine output in critically ill patients. Ann Intensive Care. 2011;1(1):13.
DOI: 10.1186/2110-5820-1-13 PMID: 21906341; PMCID: PMC3224471.
Holm C, Hörbrand F, von Donnersmarck GH, Mühlbauer W. Acute renal failure in severely burned patients. Burns. 1999;25(2):171-178.
Kuo G, Yang SY, Chuang SS, Fan PC, Chang CH, Hsiao YC. Using acute kidney injury severity and scoring systems to predict outcome in patients with burn injury. Journal of the Formosan Medical Association. 2016;115(12):1046-1052.
Han WK, Wagener G, Zhu Y, Wang S, Lee HT. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clinical Journal of the American Society of Nephrology. 2009;4(5):873- 882.
Naggar GFE, Srogy HAEL, Fathy SM. Kidney Injury Molecule-1 (KIM-1): An early novel biomarker for Acute Kidney Injury (AKI) in critically–ill patients. Life Sci J. 2012;9:3937-3943.
Abstract View: 104 times
PDF Download: 32 times